Key Inclusions
- A summary of the key insights derived from our research, which offers a high-level view on the likely evolution of the aseptic fill finish service providers market in the short to mid-term, and long term.
- A general introduction to pharmaceuticals and contract manufacturing, which features a detailed discussion on the need for outsourcing within the pharmaceutical industry and key operations outsourced by biologic and small molecule drug developers, including fill finish. It also provides information on the key considerations for selecting a fill finish service provider, along with the advantages and risks posed by outsourcing fill finish operations.
- A detailed assessment of the overall landscape of aseptic fill finish service providers, along with information on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of molecule(s) (biologics and small molecules) and type of packaging container(s) offered (ready-to-use cartridges, ready-to-use syringes and ready-to-use vials).
- A review of the overall landscape of companies offering aseptic fill finish services for biologics, along with analyses on a number of relevant parameters, such as year of establishment, company size, location of headquarters, location of fill finish facilities, type of packaging container(s) used (ampoules, cartridges, syringes and vials), type of biologic(s) manufactured (antibody drug conjugates, antibodies, biosimilars, cell therapies, gene therapies, oligonucleotides, peptides / proteins, vaccines, viral products, and others), scale of operation (preclinical, clinical and commercial) and type of additional drug product-related service(s) offered (lyophilization, labeling, quality testing, storage and distribution services).
- A detailed assessment of the overall market landscape of the companies offering aseptic fill finish services for small molecules, along with analyses on a number of relevant parameters, such as year of establishment, company size, location of headquarters, location of fill finish facilities, type of filling service(s) offered (aseptic filling, terminal streilization and blow-filling-seal), type of finishing service(s) offered (inspection and labelling and packaging), type of packaging container(s) offered (ampoules, cartridges, syringes and vials), scale of operation (preclinical, clinical and commercial), type of dosage form(s) filled (solid, liquids, lyophilized products / powders and semi-solids), type of process(es) (automated and manual / semi-automated).
- Tabulated profiles of key players based in North America, Europe and Asia-Pacific. Each profile provides an overview of the company, along with information on its service portfolio, fill finish facilities, financial information (if available), recent developments and an informed future outlook.
- A detailed analysis of the various partnerships and collaborations established by stakeholders in this domain, since 2013. It includes a brief description of different agreement models (including service agreements, service alliances, product integration agreements, joint ventures and acquisitions) adopted by stakeholders in this domain. Further, it comprises of analysis based on year of partnership, type of partnership, scale of operation, type of molecule(s), type of service(s) offered, type of process(es) involved, and type of drug product(s) filled. It also highlights the most active players (in terms of number of partnerships) in the domain.
- A case study focused on use of robotic systems in fill finish operations. It provides a list of equipment used by fill finish service providers (wherever specified), highlighting the purpose of robotics in various manufacturing operations. It also includes a list of companies offering robots for use in the manufacturing processes which are carried in the pharmaceutical sector.
- A case study on use of ready-to-use packaging components in aseptic fill finish operations. The chapter also provides information related to the advantages and disadvantages of ready-to-use packaging components, along with a list of suppliers providing these components.
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
- Type of Molecule
- Small molecules
- Biologics
- Type of Packaging Container
- Ampoules
- Cartridges
- Syringes
- Vials
- Type of Drug Product
- Antibodies
- Cell Therapies
- Gene Therapies
- Oligonucleotides
- Recombinant Proteins
- Vaccines
- Other Drug Products
- Target Therapeutic Area
- Autoimmune disorders
- Oncological Disorders
- Cardiovascular Disorders
- Infectious Diseases
- Other Disorders
- Scale Of Operation
- Preclinical / Clinical
- Commercial
- Company Size
- Large
- Mid-sized
- Small
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Middle East and North Africa
- Latin America
Key Questions Answered
- What is the aseptic fill finish?
- What are the requirements and considerations for aseptic fill finish operation?
- How many players are providing aseptic fill finish services?
- What are the latest trends in aseptic fill finish market?
- What is the growth rate of aseptic fill finish services market?
- Which region captures the largest share of the aseptic fill finish services market?
- Which segment, in terms of type of molecule, currently accounts for the largest share of the aseptic fill finish services market?
- Which types of packaging containers are most widely used in the aseptic fill finish services market?
- What type of partnerships are taking place in the aseptic fill finish services market?
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/aseptic-fill-finish-market.html
You may also be interested in the following titles:
Nanoparticle Formulation Market
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends
Roots Analysis Consulting - the preferred research partner for global firms
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
